Experienced in COVID-19

Dr. Kirk Voelker

Intensive Care Medicine
Memory Disorder Clinic At Sarasota Memorial Hospital
1540 S Tamiami Trl Ste 302, 
Sarasota, FL 
Experienced in COVID-19
Memory Disorder Clinic At Sarasota Memorial Hospital
1540 S Tamiami Trl Ste 302, 
Sarasota, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kirk Voelker is an Intensive Care Medicine provider in Sarasota, Florida. Dr. Voelker is rated as an Experienced provider by MediFind in the treatment of COVID-19. His top areas of expertise are Emphysema, Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), and Severe Acute Respiratory Syndrome (SARS).

His clinical research consists of co-authoring 7 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 2 clinical trials in the study of COVID-19.

Graduate Institution
University Of Florida College Of Medicine
Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in FL
Hospital Affiliations
Sarasota Memorial Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Memory Disorder Clinic at Sarasota Memorial Hospital
1540 S Tamiami Trl Ste 302, Sarasota, FL 34239

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvaira™ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Enrollment Status: Active_not_recruiting
Publish Date: November 14, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Spiration® Valve System for the Single Lobe Treatment of Severe Emphysema
Enrollment Status: Completed
Publish Date: May 31, 2024
Intervention Type: Other, Device
Study Phase: Not Applicable
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Hospitalized Patients With COVID-19
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Anti-CD14 Treatment in Hospitalized Patients With COVID-19
Enrollment Status: Terminated
Publish Date: June 26, 2023
Intervention Type: Other, Drug, Biological
Study Drugs: Anti-CD14, Remdesivir
Study Phase: Phase 2
INtervention Study In overweiGHT Patients With COPD
INtervention Study In overweiGHT Patients With COPD
Enrollment Status: Completed
Publish Date: April 07, 2022
Intervention Type: Behavioral
Study Phase: Not Applicable
A Randomized, Double-Blind, Parallel Group Study to Assess the Efficacy and Safety of Once Weekly Subcutaneous Injections of Pemziviptadil (PB1046), a Sustained-Release VIP (Vasoactive Intestinal Peptide) ANalogue, in Hospitalized COVID-19 Patients at HiGh Risk for Rapid Clinical Deterioration and ARDS (PB1046 VANGARD Study)
A Randomized, Double-Blind, Parallel Group Study to Assess the Efficacy and Safety of Once Weekly Subcutaneous Injections of Pemziviptadil (PB1046), a Sustained-Release VIP (Vasoactive Intestinal Peptide) ANalogue, in Hospitalized COVID-19 Patients at HiGh Risk for Rapid Clinical Deterioration and ARDS (PB1046 VANGARD Study)
Enrollment Status: Terminated
Publish Date: December 11, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 4 Less Clinical Trials

7 Total Publications

Effect of a Self Directed Lifestyle-based Weight Management Program among Patients with Comorbid COPD and Sleep Apnea: A Secondary Analysis of the INSIGHT COPD Trial.
Effect of a Self Directed Lifestyle-based Weight Management Program among Patients with Comorbid COPD and Sleep Apnea: A Secondary Analysis of the INSIGHT COPD Trial.
Journal: Annals of the American Thoracic Society
Published: October 24, 2025
Similar Doctors
Distinguished in COVID-19
Dr. Jamie Cancel
Intensive Care Medicine
Distinguished in COVID-19
Dr. Jamie Cancel
Intensive Care Medicine

Pulmonary Sleep & Critical Care Specialists

4235 Kings Hwy Unit 103, 
Port Charlotte, FL 
 (37.9 miles away)
Languages Spoken:
English
See accepted insurances

Jamie Cancel is an Intensive Care Medicine provider in Port Charlotte, Florida. Dr. Cancel is rated as an Advanced provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), and Obstructive Sleep Apnea.

Distinguished in COVID-19
Dr. Philip Wong
Intensive Care Medicine
Distinguished in COVID-19
Dr. Philip Wong
Intensive Care Medicine

Adventhealth Medical Group Pulmonology & Critical Care At Sun 'N Lake-A Hospital Department Of Adventhealth Sebring

4325 Sun N Lake Blvd Ste 102, 
Sebring, FL 
 (61.8 miles away)
863-382-1663
Languages Spoken:
English
See accepted insurances

Philip Wong is an Intensive Care Medicine provider in Sebring, Florida. Dr. Wong is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Lung Nodules, Advanced Bronchoscopy, and Gastrostomy.

Distinguished in COVID-19
Dr. Edgardo S. Soto-De
Pulmonary Medicine | Intensive Care Medicine
Distinguished in COVID-19
Dr. Edgardo S. Soto-De
Pulmonary Medicine | Intensive Care Medicine

Pulmonary Sleep And Critical Care Specialists Pl

21298 Olean Blvd, 
Port Charlotte, FL 
 (35.0 miles away)
941-629-1181
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Edgardo Soto-De is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Port Charlotte, Florida. Dr. Soto-De is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Gastrostomy, and Endoscopy. Dr. Soto-De is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Voelker's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile